Oragenics (OGEN) Institutional Ownership $1.19 +0.04 (+3.48%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$1.16 -0.02 (-2.10%) As of 08/14/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oragenics (NYSE:OGEN)CurrentInstitutional OwnershipPercentage18.71%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$269.76KNumber ofInstitutional Sellers(last 12 months)0 Get OGEN Insider Trade Alerts Want to know when executives and insiders are buying or selling Oragenics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OGEN Institutional Buying and Selling by Quarter Oragenics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025 Clear Street LLC70,619$270K0.0%N/A8.581% 5/20/2024 Virtu Financial LLC22,675$33K0.0%N/A0.506% 1/11/2023 Sara Bay Financial1,271,281$134K0.1%-36.7%1.084% 2/14/2022 GSA Capital Partners LLP410,944$183K0.0%+150.6%0.353% 1/14/2022 Sara Bay Financial2,008,117$896K0.3%+99.2%1.725% 11/15/2021 GSA Capital Partners LLP163,954$104K0.0%N/A0.141% 11/12/2021 Renaissance Technologies LLC894,205$568K0.0%+254.1%0.768% 9/17/2021 Virtu Financial LLC65,456$46K0.0%+212.9%0.056% 8/17/2021Bridgeway Capital Management LLC140,000$99K0.0%-68.8%0.121% 8/16/2021State Street Corp454,325$321K0.0%N/A0.393% 8/13/2021 Renaissance Technologies LLC252,564$178K0.0%N/A0.218% 8/13/2021 Geode Capital Management LLC731,304$515K0.0%+36.6%0.632% 8/13/2021 Vanguard Group Inc.5,031,450$3.55M0.0%+11.3%4.351% (Data available from 1/1/2016 forward) OGEN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OGEN shares? During the previous two years, the following institutional investors and hedge funds held shares of Oragenics shares: Clear Street LLC ($270K), Virtu Financial LLC ($33K).Learn more on Oragenics' institutional investors. What percentage of Oragenics' stock is owned by institutional investors? 18.71% of Oragenics' stock is owned by institutional investors. Learn more on OGEN's institutional investor holdings. Which institutional investors have been buying Oragenics' stock? The following institutional investors have purchased Oragenics' stock in the last 24 months: Clear Street LLC ($70.62K), and Virtu Financial LLC ($22.68K). How much institutional buying is happening at Oragenics? Institutional investors have bought a total of 70,619 shares in the last 24 months. This purchase volume represents approximately $269.76K in transactions. Related Companies NovaBay Pharmaceuticals Institutional Ownership Virax Biolabs Group Institutional Ownership GRI Bio Institutional Ownership CNS Pharmaceuticals Institutional Ownership CERo Therapeutics Institutional Ownership Redhill Biopharma Institutional Ownership BioVie Institutional Ownership PainReform Institutional Ownership Lipella Pharmaceuticals Institutional Ownership Qualigen Therapeutics Institutional Ownership This page (NYSE:OGEN) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access